Abstract
α-Synuclein aggregation is a hallmark pathological feature in Parkinson’s disease (PD). The conversion of α-synuclein from a soluble monomer to an insoluble fibril may underlie the neurodegeneration associated with PD. Redox-active metal ions such as iron (Fe) and copper (Cu) are known to enhance α-synuclein fibrillogenesis. In the present investigation, we analyzed the binding efficiency of Cu and Fe to α-synuclein by fluorescence studies. It is interesting to note that Cu and Fe showed differential binding pattern toward α-synuclein (wild type and A30P, A53T, and E46K mutant forms) as revealed by intrinsic tyrosine fluorescence, thioflavin-T fluorescence, 1-anilino-8-naphthalenesulfonate-binding studies, and scatchard plot analysis. The experimental data might prove useful in understanding the hierarchy of metals binding to α-synuclein and its role in neurodegeneration.
References
Bharathi, Indi, S. S., & Rao, K. S. J. (2007). Copper and iron induced differential morphology of fibrils in α-synuclein: TEM study. Neuroscience Letters, 424, 78–82.
Bharathi, & Rao, K. S. J. (2007). Thermodynamics imprinting reveals differential binding of metals to a-synuclein: Relevance to Parkinson’s disease. Biochemical and Biophysical Research Communications, 359, 115–120.
Conway, K. A., Lee, S. J., Rochet, J. C., Ding, T. T., Williamson, R. E., & Lansbury Jr., P. T. (2000). Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy. Proceedings of the National Academy of Sciences of the USA, 97, 571–576.
Dexter, D. T., Carayon, A., Agid, F. J., Agid, Y., Wells, F. R., Daniel, S. E., et al. (1991). Alterations in the levels of iron, ferritin and other trace metals in Parkinson’s disease and other neurodegenerative diseases affecting the basal ganglia. Brain, 114, 1953–1975.
Eftink, M. R., & Ghiron, C. A. (1981). Fluorescence quenching studies with proteins. Analytical Biochemistry, 114, 199–227.
Goedert, M. (2001). α-synuclein and neurodegenerative diseases. Nature Reviews Neuroscience, 2, 492–501.
Guilloreau, L., Damian, L., Coppel, Y., Mazarguil, H., Winterhalter, M., & Faller, P. (2006). Structural and thermodynamically properties of Cu (II) amyloid-beta16/28 complexes associated with Alzheimer’s disease. Journal of Biological Inorganic Chemistry, 11, 1024–1038.
Iwai, A. E., Masliah, M., Yoshimoto, N., Ge, L., Flanagan, H. A., de Silva, A., et al. (1995). The precursor protein of non-Ab component of Alzheimer’s disease amyloid is a presynaptic protein of the central nervous system. Neuron, 14, 467–475.
Jakes, R., Spillantini, M. G., & Goedert, M. (1994). Identification of two distinct synucleins from human brain. FEBS Letters, 345, 27–32.
Jankowska, T. K., Rajewska, A., Jankowska, E., Wisniewska, K., & Grzonka, Z. (2006). Products of Cu (II)-catalyzed oxidation of the N-terminal fragments of alpha-synuclein in the presence of hydrogen peroxide. Journal of Inorganic Biochemistry, 100, 1623–1631.
Le Couteur, D. G., McLean, A. J., Taylor, M. C., Woodham, B. L., & Board, P. G. (1999). Pesticides and Parkinson’s disease. Biomedicine & Pharmacotherapy, 53, 122–130.
Maji, S. K., Amsden, J. J., Rothschild, K. J., Condron, M. M., & Teplow, D. B. (2005). Conformational dynamics of amyloid beta-protein assembly probed using intrinsic fluorescence. Biochemistry, 44, 13365–13376.
Maroteaux, L., Campanelli, J. T., & Scheller, R. H. (1998). Synuclein: A neuron specific protein localized to the nucleus and presynaptic nerve terminal. Journal of Neuroscience, 8, 2804–2815.
Matulis, D., Baumann, C. G., Bloomfield, V. A., & Lovrien, R. E. (1999). 1-Anilino-8-naphthalene sulfonate as a protein conformational tightening agent. Biopolymers, 49, 451–458.
Matulis, D., & Lovrien, R. (1998). 1-Anilino-8-naphthalene sulfonate anion-protein binding depends primarily on ion pair formation. Biophysical Journal, 74, 422–429.
Pandey, N., Schmidt, R. E., & Galvin, J. E. (2006). The alpha-synuclein mutation E46K promotes aggregation in cultured cells. Experimental Neurology, 197, 515–520.
Semisotnov, G. V., Rodionova, N. A., Razgulyaev, O. I., Uversky, V. N., Gripas, A. F., & Gilmanshin, R. I. (1991). Study of the “molten globule” intermediate state in protein folding by a hydrophobic fluorescent probe. Biopolymers, 31, 119–128.
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998). Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies. Proceedings of the National Academy of Sciences of the USA, 95, 6469–6473.
Spillantini, M. G., Schimdt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997). α-synuclein in Lewy bodies. Nature, 388, 839–840.
Sung, Y. H., Rospigliosi, C., & Eliezer, D. (2006). NMR mapping of copper binding sites in alpha-synuclein. Biochimica et Biophysica Acta, 1764, 5–12.
Tanner, C. M. (1989). The role of environmental toxins in the etiology of Parkinson’s disease. Trends in Neurosciences, 12, 49–54.
Uversky, V. N., Li, J., & Fink, A. L. (2001a). Evidence for a partially folded intermediate in α-synuclein fibril formation. Journal of Biological Chemistry, 276, 10737–10744.
Uversky, V. N., Li, J., & Fink, A. L. (2001b). Metal-triggered structural transformation, aggregation and Fibrillation of Human α-synuclein, a possible molecular link between Parkinson’s disease and heavy metal exposure. Journal of Biological Chemistry, 276, 44284–44296.
Yasui, M., Kihira, T., & Ota, K. (1992). Calcium, magnesium aluminium concentrations in Parkinson’s disease. Neurotoxicology, 13, 593–600.
Zarranz, J. J., Alegre, J., Gomez-Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., et al. (2004). The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Annals of Neurology, 55, 164–173.
Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., & Gallorini, M. (2004). The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proceedings of the National Academy of Sciences of the USA, 101, 9843–9848.
Acknowledgments
The authors are indebted to Dr. V. Prakash, Director, Central Food Technological Research Institute, Mysore for his support and encouragement. The authors profoundly thankful to Dr. Rivka Ravid, Senior Advisor, The Netherlands Academy of Science and Netherlands Brain Bank, The Netherlands for reviewing the manuscript and providing constructive comments. The authors thank Prof. Raghavan Varadarajan, Molecular Biophysics Unit, Indian Institute of Science, Bangalore for providing the facility. Bharathi is thankful to Council for Scientific and Industrial Research for awarding senior research fellowship. This work was supported by a grant from Department of Atomic Energy, through BNRS project, Mumbai, India.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bharathi, Rao, K.S.J. Molecular Understanding of Copper and Iron Interaction with α-Synuclein by Fluorescence Analysis. J Mol Neurosci 35, 273–281 (2008). https://doi.org/10.1007/s12031-008-9076-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-008-9076-4